S
Samjin Pharmaceutical Co Ltd
KRX:005500
Samjin Pharmaceutical Co Ltd
KRX:005500
Price:
17 970
KRW
-1.16%
Market Closed
Market Cap:
₩225.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
KR |
|
Sosandar PLC
LSE:SOS
|
UK |
|
Dong-Ah Geological Engineering Co Ltd
KRX:028100
|
KR |
|
Industria de Diseno Textil SA
OTC:IDEXY
|
ES |
|
Maharah for Human Resources Company SJSC
SAU:1831
|
SA |
|
Yu Tak International Holdings Ltd
HKEX:8048
|
HK |
|
GS Engineering & Construction Corp
KRX:006360
|
KR |
|
GPT Infraprojects Ltd
NSE:GPTINFRA
|
IN |
|
G
|
Gold Royalty Corp
AMEX:GROY
|
CA |
Multiples-Based Value
The Multiples-Based Value for Samjin Pharmaceutical Co Ltd (005500) under the Base Case is hidden KRW. Compared with the current market price of 17 970 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Samjin Pharmaceutical Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Samjin Pharmaceutical Co Ltd Competitors
Samjin Pharmaceutical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
220.3B KRW | 0.7 | 10 | 6.3 | 10 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
869B USD | 13.3 | 42.1 | 28.4 | 30.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.6B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4.1 | 19.4 | 11.5 | 13 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
227.8B GBP | 5.3 | 30.6 | 16.9 | 23.8 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.1 | 12.3 | |
| CH |
|
Novartis AG
SIX:NOVN
|
231.9B CHF | 5.4 | 21.7 | 13.4 | 17.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
159.7B USD | 2.6 | 20.5 | 7.8 | 10.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.6 | 9 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
